Magellan Health Reports 2019 Financial Results and Provides 2020 Guidance

Go back to Magellan Health Reports 2019 Financial Results and Provides 2020 Guidance

Magellan Health (MGLN) Tops Q4 EPS by 27c, FY EPS Guidance Comes in LIght

February 28, 2020 6:32 AM EST

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.24, $0.27 better than the analyst estimate of $0.97. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.83 billion.

GUIDANCE:

Magellan Health sees FY2020 EPS of $3.34-$4.14, versus the consensus of... More